| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $648.32K | $753.42K | $610.97K | $1.23M | $855.78K |
| R&D | – | – | – | – | – |
| SG&A | $24.29K | $28.05K | $35.55K | $32.62K | $13.79K |
| Operating Income | -$648.32K | -$753.42K | -$610.97K | -$1.23M | -$855.78K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$495.80K | -$964.60K | -$618.19K | -$1.42M | -$1.75M |
| EPS (basic) | – | – | -0.0100 | -0.0100 | – |
| EPS (diluted) | 0.0000 | -0.0100 | -0.0100 | – | – |
| Shares (diluted) | $117.89M | $117.89M | $116.11M | – | – |